Call for proposals to support Member States and other relevant actors to implement relevant results of innovative public health research in relation to vaccination against COVID-19

Closed

Programme Category

EU Competitive Programmes

Programme Name

EU4Health Programme 2021-2027

Programme Description

The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:

  • protecting people from serious cross-border health threats
  • improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
  • strengthening national health systems
Programme Details

Identifier Code

EU4H-2022-PJ-16

Call

Call for proposals to support Member States and other relevant actors to implement relevant results of innovative public health research in relation to vaccination against COVID-19

Summary

The action aims to support Member States and relevant stakeholders to implement the results of recent and relevant research in relation to vaccination against COVID19. 

Detailed Call Description

The action should cover the following funded activities:

  • mapping public health evidence and research results on COVID-19 large-scale vaccination that could be relevant for uptake, including findings, from Member States and outside of the Union;
  • identifying challenges and assess the feasibility to implement solutions in Member States, based on the mapping and taking country-specific factors into account;
  • developing implementation plans and pilot activities to respond to the current pandemic context or future health crises, or to optimise current routine vaccination practices, including catch-up vaccination;
  • implementing the pilot activities in volunteering Member States including the activities identified as potentially most effective (e.g. training programmes for health professionals, awareness-raising campaigns to tackle vaccine hesitancy, health preparedness training programmes, infrastructure initiatives, dedicated events for the exchange of good practices, risk communication and community engagement etc.);
  • identifying successful pilot activities and, based on these, develop a robust sustainability plan for continued implementation and toolkits and recommendations for upscaling in other Member States.

The action is expected to deliver an inventory of relevant innovative public health research on COVID19 large-scale vaccination and implement plans in relevant Member States taking into account feasibility and country specific factors. This will result, based on pilot projects implemented in several Member States and, after assessment, in the development of sustainability plans and toolkits and recommendations.

Call Total Budget

€18,400,000

Financing percentage by EU or other bodies / Level of Subsidy or Loan

Project budgets (maximum grant amount) are expected to be around € 1,800,000 per project.

 The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%). Your organisation can apply for a higher project funding rate (80%) if your project is of “exceptional utility”. Actions shall be considered to have exceptional utility where at least 30% of the budget of the proposed action is allocated to Member States whose GNI per inhabitant is less than 90% of the Union average; or the project concerns actions with bodies from at least 14 Member States and where at least four (4) are from Member States whose GNI per inhabitant is less than 90% of the EU average.

Thematic Categories

  • Education and training
  • Health
  • Research, Technological Development and Innovation

Eligibility for Participation

  • Associations
  • Central Government
  • Educational Institutions
  • Local Authorities
  • NGOs
  • Non Profit Organisations
  • Private Bodies
  • Researchers/Research Centers/Institutions
  • Semi-governmental organisations
  • State-owned Enterprises

Eligibility For Participation Notes

In order to be eligible for funding, the applicants (beneficiaries and affiliated entities) must be legal entities (public or private bodies) established in EU Member States or EEA countries and countries associated to the EU4Health Programme or countries which are in ongoing negotiations for an association agreement.

Specific eligibility criteria:

Academia and education establishments, research institutes, hospitals, expert networks, private entities, Member States’ authorities, and civil society organisations (associations, foundations, NGOs and similar entities).

Applicants must have extensive experience in public health and the planning and/or implementation of vaccination programmes, with a minimum of 10 years of proved experience.

Consortium composition: Proposals by single applicants (single beneficiaries) as well as proposals submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities) are allowed.

Call Opening Date

15/12/2022

Call Closing Date

16/03/2023

National Contact Point(s)

Ministry of Health, Department of European Affairs

Ms MAKRIGIORGI Elena
emakrigiorgi@moh.gov.cy

(Publish Date: 20/12/2022-for internal use only)

EU Contact Point

Stefan DE KEERSMAECKER
Telephone: +32 2 298 46 80
Email: stefan.de-keersmaecker@ec.europa.eu

Darragh CASSIDY

Telephone: +32 2 298 39 78
Email: darragh.cassidy@ec.europa.eu